Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.
The Anti-dsDNA Antibody Test detects antibodies against double-stranded DNA, which are commonly associated with autoimmune diseases like Systemic Lupus Erythematosus (SLE).
This test is used to diagnose SLE, monitor disease activity, assess treatment response, and differentiate between autoimmune diseases.
No special preparation is needed. You can eat and drink normally. Inform your healthcare provider about any medications or health conditions.
Results are typically available within 1 to 2 days after the test.
A positive result suggests the presence of antibodies associated with autoimmune activity, particularly in Systemic Lupus Erythematosus (SLE). Further evaluation is often required to confirm the diagnosis and assess disease activity.
Enhanced External Counterpulsation (EECP) therapy is a non-invasive treatment that helps improve blood flow to the heart and relieve symptoms of angina and heart failure.
EECP therapy uses inflatable cuffs wrapped around the legs to compress and decompress the blood vessels, promoting increased blood flow to the heart during the relaxation phase of the heartbeat.
Patients with chronic stable angina, heart failure, or those who are not suitable candidates for invasive procedures like angioplasty or bypass surgery may benefit from EECP therapy.
EECP therapy can help reduce angina symptoms, improve exercise tolerance, enhance the quality of life, and decrease the need for medication in some patients.
Each EECP session typically lasts about one hour and is usually conducted five days a week for a total of seven weeks.
HBsAg is a surface antigen of the hepatitis B virus, detected in the blood during HBV infection.
Individuals at risk of HBV infection or needing routine screening should undergo this test.
No, the test involves a simple blood draw, which may cause slight discomfort but is generally well-tolerated.
A positive result indicates the presence of HBV infection.
No, additional tests may be required to distinguish between acute and chronic infection.